MedTrace Logo

Clinical Intervention Psychosis and Addiction

NCT01411566 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2011-08-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.

Conditions

Interventions

BEHAVIORAL

Skills trainig for patients with dual diagnosis

Skills trainig for patients with dual diagnosis

BEHAVIORAL

regular treatment

regular treatment

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Joerg Daumann, PhD · University of Cologne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01411566 on ClinicalTrials.gov